A&O Shearman Slovakia’s Post

💉 Financing medical practices “The wide variety of CPOM restrictions across jurisdictions impose unique challenges for private equity sponsors investing in, and lenders financing, medical practices. A comprehensive MSO structure together with carefully negotiated financing covenants and conditions may largely mitigate many of the structural gaps and risks associated with the inability of the sponsor to own or pledge, or provide direct credit support from, such medical practices.” In this chapter, Scott Herrig, David Kennedy and Matthew Wiener of Davis Polk & Wardwell LLP describe the structuring, diligence and loan documentation considerations for lenders providing financing for medical practice acquisitions subject to CPOM restrictions. 🔗 https://lnkd.in/eTasTty8 #Lending

📈 Dive into the world of equities with MeDirect! 💼 Invest in stocks and let your money grow with the market. Start Today 👉 https://lnkd.in/dZddKRtu #MeDirect #MyMoneyMyChoices #MyInvestmentsMyWay #Invest #Investment #WealthManagement #Equities #GrowthInvesting #WealthAcceleration MeDirect Bank (Malta) plc, company registration number C34125, is licensed by the Malta Financial Services Authority to undertake the business of investment services under the Investment Services Act (Cap. 370). When investing you may lose some or all of the money you invest. The value of your investment may go down, as well as up. Any income you get from this investment may go down, as well as up. A commission or sales fee may be charged when trading in these securities. MeDirect Bank (Malta) plc, The Centre, Tigné Point, Sliema, TPO 0001, Malta.

Medical Developments International (ASX:MVP) projects $31M non-cash asset writedowns in FY24 - Medical Developments International (MDI) #Investment #ASX

Shareholders in medical diagnostics business Integrated Diagnostics Holdings - IDH have voted in favour of a voluntary delisting from the Egyptian Stock Exchange 👇🏾👇🏾 𝐈𝐃𝐇 𝐭𝐨 𝐝𝐞𝐥𝐢𝐬𝐭 𝐟𝐫𝐨𝐦 𝐄𝐠𝐲𝐩𝐭, 𝐫𝐞𝐭𝐚𝐢𝐧 𝐋𝐨𝐧𝐝𝐨𝐧 𝐥𝐢𝐬𝐭𝐢𝐧𝐠 "Speaking last month, CEO Dr Hend El Sherbini said that the reason for exiting the EGX was to improve liquidity in the company’s shares. Since listing on the EGX in 2021, IDH’s share price has fallen nearly 97%. That’s despite a relatively robust financial performance over the years. Its London share price has fallen 79% since listing in 2015. Last month, it reported a 139% jump in net profit growth for 1Q24 compared to the same period last year. Egypt contributed over 80% of total revenues in 2023." — Chipo Muwowo, Managing Editor, Capital Markets Africa https://lnkd.in/eQrr_nGD Disclaimer: Capital at risk. #investinginAfrica #Africanequities #Africanstocks #Africancapitalmarkets #Egypt

Ulysses stands at the forefront of healthcare consolidation in the GCC, taking advantage of a fragmented market, limited competition in small asset consolidation, and a strong demand for exit strategies among healthcare business owners. Ulysses positions itself as a solution-driven M&A company that delivers solid results over time. #UlyssesInvestment #Ulyssesadvisory #AdvisoryServices #UAEbusiness #MiddleEastExpansion #DubaiOpportunities #BusinessGrowth #InvestmentOpportunities #DubaiBusiness #MiddleEastMarket #AcquisitionStrategy #MiddleEastAdvisors

Following a long arm wrestling with the Belgian Competition Authority (BCA), the Belgian legislator adopted this year a law, which finally excludes hospitals from merger control under the Belgian Code of Economic Law. This act comes after a period of turmoil between the BCA and the Belgian legislator on the application of merger control in the hospital sector.   Find out more here: https://lnkd.in/gdxHCyfK   If you have any questions, contact Annabelle Lepièce and Sébastien Willems   #CMSlaw #law #mergercontrol #competitionlaw #lifesciences #healthcare

Blake is 100% correct- if you're a a Contract Research Organization (CRO) you must attend this webinar! How are CROs providing more options and solutions to their customers through partnering with tech vendors? How can CROs improve their profitability via these relationships? May 16th, 11am EST- register using Blake's link below:

I can't think of a better panel to highlight the approaches leading CROs are taking to build new profit centers through strategic partnerships with leading technology and service solutions, while reducing investigator site burden and increasing the operational efficiency of clinical trials. Register for the webinar at the link in comments below.

Have you ever wished you hadn't signed a CTA after the fact? After you learned the a sponsor or CRO doesn't pay their bills? Or after sponsors learn sites are only milking screen failures without truly trying, taking startup payments and running, and draining their budgets? Clinical Research Payment Network builds protections for both our site partners and our sponsor members. Our revolutionary PACT score maintains a credit rating for the stakeholders in our industry. High credit ratings result in better trial awards and lower premiums. Low credit ratings lead to higher premiums and, if they cannot be reconciled, dismissal from the network. Make informed business decisions. Join CRPN today and empower your trial activities with our PACT surveys and scores. #Experience the ▲ #crpn

Before choosing a partner, it is a good idea to speak with at least 10 qualified organizations and to meet with 5 or more. LPS can help you find the partner that is best for you and your practice. Contact us for a no-obligation valuation and see if an IDSO partnership is right for you! https://bit.ly/3F40xel #IDSO #PracticePartnership #IDSOBusinessValuation #BusinessConsultation #StrategicPartnership #DentalPractice #DentalIndustry #DentalPartnership #IDSOPartnership #LPS #LargePracticeSales